GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » EKF Diagnostics Holdings PLC (LSE:EKF) » Definitions » EBITDA Margin %

EKF Diagnostics Holdings (LSE:EKF) EBITDA Margin % : 17.14% (As of Dec. 2023)


View and export this data going back to 2002. Start your Free Trial

What is EKF Diagnostics Holdings EBITDA Margin %?

EBITDA Margin % is calculated as EBITDA divided by its Revenue. EKF Diagnostics Holdings's EBITDA for the six months ended in Dec. 2023 was £4.41 Mil. EKF Diagnostics Holdings's Revenue for the six months ended in Dec. 2023 was £25.74 Mil. Therefore, EKF Diagnostics Holdings's EBITDA margin for the quarter that ended in Dec. 2023 was 17.14%.


EKF Diagnostics Holdings EBITDA Margin % Historical Data

The historical data trend for EKF Diagnostics Holdings's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

EKF Diagnostics Holdings EBITDA Margin % Chart

EKF Diagnostics Holdings Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EBITDA Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 22.30 30.71 33.47 -3.27 14.59

EKF Diagnostics Holdings Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
EBITDA Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 29.99 20.20 -33.44 12.15 17.14

Competitive Comparison of EKF Diagnostics Holdings's EBITDA Margin %

For the Medical Devices subindustry, EKF Diagnostics Holdings's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


EKF Diagnostics Holdings's EBITDA Margin % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, EKF Diagnostics Holdings's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where EKF Diagnostics Holdings's EBITDA Margin % falls into.



EKF Diagnostics Holdings EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

EKF Diagnostics Holdings's EBITDA Margin % for the fiscal year that ended in Dec. 2023 is calculated as

EBITDA Margin %=EBITDA (A: Dec. 2023 )/Revenue (A: Dec. 2023 )
=7.678/52.611
=14.59 %

EKF Diagnostics Holdings's EBITDA Margin % for the quarter that ended in Dec. 2023 is calculated as

EBITDA Margin %=EBITDA (Q: Dec. 2023 )/Revenue (Q: Dec. 2023 )
=4.412/25.739
=17.14 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


EKF Diagnostics Holdings  (LSE:EKF) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.


EKF Diagnostics Holdings EBITDA Margin % Related Terms

Thank you for viewing the detailed overview of EKF Diagnostics Holdings's EBITDA Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


EKF Diagnostics Holdings (LSE:EKF) Business Description

Traded in Other Exchanges
Address
19 Stanwell Road, Penarth, Avon House, Cardiff, GBR, CF64 2EZ
EKF Diagnostics Holdings PLC is engaged in the field of medical diagnostics. The company's core business is point-of-care testing and manufacturing reagents for use in central laboratories. It caters to companies focused on areas such as diabetes, blood banking, and sports medicine. The company derives its income from its sales in the United States. Its other markets include Germany, Poland, and Russia.

EKF Diagnostics Holdings (LSE:EKF) Headlines

No Headlines